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Background: Wnt signaling causes 
phosphorylation of Dishevelled, but its functional 
significance is unclear. 
Result: Sites of Wnt-induced phosphorylation 
were mapped in Dvl2 and mutated to permit 
functional testing.  
Conclusion: Three CK1 phosphorylation sites in 
the C-terminal of Dvl2 account for the Wnt 
induced mobility shift and modulate signaling.  
Significance: Wnt-induced phosphorylation of 
Dvl differentially regulates canonical and non-
canonical Wnt signaling. 
 
SUMMARY 
Dishevelled (Dvl) proteins are intracellular 
effectors of Wnt signaling that have essential 
roles in both canonical and non-canonical Wnt 
pathways.  It has long been known that Wnts 
stimulate Dvl phosphorylation, but relatively 
little is known about its functional significance.  
We have previously reported that both Wnt3a 
and Wnt5a induce Dvl2 phosphorylation that is 
associated with an electrophoretic mobility shift 
and loss of recognition by monoclonal antibody 
10B5.  In the present study, we mapped the 
epitope to a 16-amino acid segment of human 
Dvl2 (residues 594-609) that contains four 
Ser/Thr residues.  Alanine substitution of these 
residues (P4m) eliminated the mobility shift 
induced by either Wnt3a or Wnt5a.  The Dvl2 
P4m mutant showed a modest increase in 
canonical Wnt/β-catenin signaling activity 
relative to wild-type.  Consistent with this 
finding, Dvl2 4Pm preferentially localized to 
cytoplasmic puncta.  In contrast to wild-type 
Dvl2, however, the 4Pm mutant was unable to 
rescue Wnt3a-dependent neurite outgrowth in 
TC-32 cells following suppression of 
endogenous Dvl2/3. Earlier work has 
implicated casein kinase 1δ/ as responsible for 
the Dvl mobility shift, and a CK1 in vitro 
kinase assay confirmed that Ser594, Thr595 
and Ser597 of Dvl2 are CK1 targets.  Alanine 
substitution of these 3 residues was sufficient to 
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abrogate the Wnt-dependent mobility shift.  
Thus, we have identified a cluster of Ser/Thr 
residues in the C-terminal domain of Dvl2 that 
are Wnt-induced phosphorylation (WIP) sites.  
Our results indicate that phosphorylation at the 
WIP sites reduces Dvl accumulation in puncta, 
and attenuates -catenin signaling, while it 
enables non-canonical signaling that is required 
for neurite outgrowth. 
            
   Dishevelleds (Dvls) are multifunctional 
intracellular proteins that were first identified 
through their essential role in the transduction of 
signals elicited by members of the Wnt family of 
secreted proteins  (1-3).  Wnt proteins themselves 
are widely known critical regulators of embryonic 
and postnatal development.  They control diverse 
aspects of cell behavior including cell polarity and 
stem cell self-renewal, and aberrant Wnt signaling 
is associated with numerous human diseases, 
including cancer  (4,5).   
   Intracellular signaling triggered by Wnt proteins 
is generally classified in two functional categories: 
canonical and non-canonical, based on the 
involvement of β-catenin as a signaling 
intermediate  (5,6).  Canonical Wnt signaling is 
initiated by binding of Wnt proteins to a Frizzled-
LRP5/6 receptor complex  (7).  This leads to 
stabilization of cytoplasmic β-catenin by inhibiting 
phosphorylation events that otherwise target the 
protein for proteasomal destruction.  The 
stabilized β-catenin also accumulates in the 
nucleus where, together with Tcf/Lef proteins, it 
regulates the transcription of specific target genes 
(5,7).  Wnt1 and Wnt3a are examples of Wnt 
ligands that typically activate canonical Wnt/β-
catenin signaling (8), although they also stimulate 
other Wnt signaling pathways (9-12). 
   In contrast to the above mechanism, non-
canonical Wnt signaling can be broadly defined as 
an intracellular response to Wnt proteins that does 
not involve stabilization of β-catenin.  There are 
numerous instances of such signaling in 
development, particularly associated with planar 
cell polarity (PCP) and the movement of cells 
during morphogenesis (6,13).  More recent data 
also implicate non-canonical Wnt signaling in the 
regulation of tumor cell invasiveness and motility 
(14-17). Wnt5a is currently the best-studied Wnt 
protein that usually signals via non-canonical 
mechanisms (17,18).  Through genetic and 
biochemical studies in diverse organisms, several 
pathways of non-canonical Wnt signaling have 
been proposed, such as the Wnt/PCP, Wnt/Ca2+, 
and Wnt/Ror2 pathways (19-22).  However, many 
details of these pathways remain obscure and there 
may be additional non-canonical signaling 
mechanisms. 
   Dishevelled (Dvl) proteins are among the few 
signaling intermediaries common to both modes of 
Wnt signaling, canonical and non-canonical.  In 
mammals there are three isoforms, Dvl-1, 2, and 3, 
which are products of paralogous genes.  Each has 
a conserved domain structure comprising DIX, 
PDZ, and DEP domains, followed by a C-terminal 
domain (CTD) (3). Several other proteins can bind 
Dvls and the latter have thus been referred to as 
scaffold proteins (3,23).  Dvl proteins also have a 
capacity to form multimeric complexes and this 
can be promoted by Wnt signaling (24-26).  In 
canonical signaling, such multimers may be 
recruited to Wnt receptors to form signalosomes, 
which, in turn, recruit Axin and other proteins that 
inactivate the β-catenin destruction complex 
(27,28).   
   All three mammalian Dvl proteins become 
phosphorylated in response to Wnt signals, a 
feature that is detectable as a mobility shift on 
SDS-polyacrylamide gels (12,29). Although the 
phosphorylated and shifted form (‘psDvl’) has 
sometimes been assumed to be a sign of 
‘activation’ in terms of downstream signaling, the 
kinetics of Wnt-induced Dvl phosphorylation 
appear too slow to be able to precede the 
stabilization of β-catenin in canonical signaling 
(12,30-33).  Moreover, we and others have shown 
that Dvl becomes phosphorylated, not only in 
response to Wnts that stimulate the canonical 
pathway, but also in response to those such as 
Wnt5a that do not stabilize β-catenin 
(12,30,33,34).  As Wnt-induced phosphorylation 
of Dvl can occur in the absence of β-catenin 
stabilization, and is independent of the LRP5/6 
Wnt receptor components required for canonical 
Wnt signaling, we have previously argued that 
psDvl is a manifestation of non-canonical Wnt 
signaling (12).  However, the functional 
consequences of Dvl phosphorylation for either 
mode of Wnt signal transduction have remained 
unclear.   
   Several kinases have been reported to bind 
and/or phosphorylate Dvl, including casein kinase 
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1 delta and epsilon (CK1/), casein kinase 2, 
PAR-1, Plk1, and protein kinase C (reviewed in  
(3)).  Dozens of phosphorylation sites have been 
documented in Dvl proteins, and some have been 
identified as targets of specific kinases (35-38).  
While phosphorylation sites are widely distributed 
in the Dvl sequence, they are particularly abundant 
in the CTD (35).  Deletion analysis and site-
directed mutagenesis have suggested that 
phosphorylation in this region correlates with 
formation of psDvl (12,35,39).  Furthermore, it 
has been proposed that CK1/ are primarily 
responsible for CTD phosphorylation and the 
corresponding mobility shift (39).  However, CK1 
is able to phosphorylate other Wnt signaling 
components besides Dvl, and regulates their 
function (40,41).  Thus it has proved difficult to 
investigate functional consequences of Dvl 
phosphorylation in isolation from pleiotropic 
effects of altered kinase levels.    
In the present study we identify a cluster of 
three Ser/Thr residues in Dvl2 that constitutes a 
key target of Wnt-induced phosphorylation in vivo 
and is a target for CK1 phosphorylation in vitro.  
Mutation of the three amino acids to Ala prevents 
the shift in electrophoretic mobility of Dvl2 in 
response to either Wnt3a or Wnt5a.  Our data 
further indicate that the Wnt-induced 
phosphorylation normally observed at these 
residues in wild-type Dvl results in attenuation of 
canonical Wnt signaling and concomitant 
stimulation of non-canonical activity.   
 
EXPERIMENTAL PROCEDURES  
    Cell culture and neurite outgrowth. Rat2 
fibroblasts and HEK293T cells were maintained in 
Dulbecco’s modified Eagle medium containing 
10% fetal bovine serum (FBS; Life Technologies).  
C57MG cells were cultured in the same medium 
supplemented with 10 g/ml insulin (Invitrogen). 
The ESFT cell line TC-32 was grown on cell 
culture dishes, cluster plates or glass coverslips 
pre-coated with type I collagen solution (Sigma-
Aldrich, St. Louis, MO) as described (10).  Wnt-
stimulated neurite outgrowth was induced and 
quantified as previously described (10). 
    Recombinant protein and conditioned medium. 
Recombinant Wnt3a was purchased from R&D 
Systems (Minneapolis, MN).  Secreted Frizzled-
Related protein (sFRP-1) was prepared as 
described (42).  Wnt5a CM was harvested from 
Rat2/Wnt5a cells in DMEM + 1% FBS, 
centrifuged at 2000 x g for 10 min, and 
concentrated 10-fold using Centriplus YM-10 
columns (Millipore).  Wnt3a CM was obtained 
from L/Wnt3a cells as previously described (12). 
    Antibodies used for Western blotting. Mouse 
anti-Dvl-2 (10B5), rabbit anti-Dvl-2 (H-75), 
mouse anti-Myc (9E10), and mouse anti-HSP70 
were from Santa Cruz Biotechnology (Santa Cruz, 
CA). Rabbit anti-Dvl2 (cat#3216) and rabbit anti-
Dvl3 (cat#3218) were from Cell Signaling 
Technology, Inc (Danvers, MA). Mouse anti-β-
catenin (C19220) and mouse anti-GSK3β (clone 7) 
were from BD Transduction Labs (San José, CA).  
Mouse FLAG (M2) antibody was obtained from 
Sigma-Aldrich.  
    Immunoblotting. For Western blot analysis of 
Rat2 and HEK293T cells, lysates were prepared in 
RIPA buffer and processed as previously 
described (12). Separation of phosphorylated 
forms of Dvl was achieved using 7% 
polyacrylamide gels in Tris-glycine buffer. For 
verification of siRNA-knockdown of endogenous 
proteins, TC-32 cells transfected with siRNA were 
harvested 48 h after transfection and processed for 
SDS-PAGE and Western blot analysis as 
previously described (10).  
    Recombinant DNA.  Human Dvl2 cDNA was 
cloned into pcDNA3.1-mycHisA (Invitrogen) 
using NotI and XhoI sites.  hDvl2 deletion 
constructs were then generated by PCR using 3’-
specific primers.      Site-directed mutagenesis for 
production of hDvl mutants was performed using a 
QuikChange II Mutagenesis Kit (Agilent 
Technologies, Inc. Santa Clara, CA) and all 
mutations were verified by DNA sequencing.  
Myc-tagged hDvl2 mutants and WT were sub-
cloned into the retroviral vector pLNCX, using 
SnaBI and StuI sites, for stable expression in Rat2 
cells (see below).  pCS2+ FLAG-mDvl2 WT was 
kindly provided by X. He (Harvard University) 
and mDvl2 P4m was generated from this by site-
directed mutagenesis as above.  pcDNA3.3 Myc-
tagged mCK1δ and mCK1ε were prepared as 
described (43). For pCMV32 lentiviral constructs 
Gateway entry clones were first generated from 
pCS2+ FLAG-mDvl2 WT and P4m and lentiviral 
expression clones were then constructed using 
Multisite Gateway recombinational cloning 
(Invitrogen). 
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    Retroviral and lentiviral expression. LNCX 
retroviral vectors expressing Myc-tagged WT or 
mutant hDvl2 were packaged in BOSC23 cells, 
and the viruses used to transduce Rat2 cells with 
selection in G418 (Geneticin) (44). Lentiviral 
particles were produced by transient transfection 
of HEK293T cells and concentrated 10-fold with 
Amicon Ultra-15 (Millipore, Billerica, MA). For 
lentiviral transduction, TC-32 cells at 80-90% 
confluency in a 6 well plate were infected with 0.2 
ml of concentrated lentivirus in 1 ml of medium 
and 8 μg/ml polybrene (Millipore) and left for 24 
h. Selection was performed in Geneticin (400 
μg/ml) and the cells subjected to Western blotting 
to verify recombinant protein expression.  
    DNA transfection and TOPflash assays. For 
10B5 epitope mapping, HEK293T cells were 
transiently transfected with Myc-tagged hDvl2 
deletion constructs in pcDNA3.1 using the DNA-
calcium phosphate co-precipitation method and 
harvested 48 h later for immunoblotting as 
described above. TOPflash assays were performed 
by transfection of 293T cells with FuGENE 
(Promega) using a Dual Luciferase Reagent kit 
(Promega) largely as described previously (45,46). 
Plasmid pMT23-β-catenin (46) was used as a 
positive control for canonical Wnt signaling. Tcf-
mediated reporter activity was normalized to the 
activity of pRL-TK. 
    DNA transfection and analysis of endogenous 
gene expression by quantitative PCR. C57MG 
cells were transfected with pCS2 (empty vector), 
pCS2+ FLAG-mDvl2 WT or P4m using the Neon 
Transfection System (Invitrogen). 106 cells were 
placed in 100 l resuspension buffer and 
combined with 1 g of plasmid.  Electroporation 
was performed with two pulses having a width 
range of 20 ms and 1400 V.  Transfected cells 
were resuspended in 500 l growth medium and 
divided into two wells of a 6-well plate, each 
containing 2 ml growth medium. After 24 h, 
medium was replaced with DMEM lacking 
supplements and 1 h later cells were treated for 6 h 
with 50 ng/ml Wnt3a or bovine serum albumin 
(BSA, 8 g/ml) as carrier protein control. RNA 
was isolated with RNeasy Kit (Qiagen) and cDNA 
generated with QuantiTect Reverse Transcription 
Kit (Qiagen). Quantitative PCR was performed as 
previously described (47). -actin was quantified 
in each cDNA sample to normalize results.  Data 
analysis was performed with MxPro software. 
    siRNA transfection. Dvl2 siRNA targeting the 
3’UTR sequence of human Dvl2 was from Qiagen 
(Valencia, CA); Dvl3 pooled siRNA and Luc 
siRNA was from Dharmacon (Lafayette, CO). 
siRNA transfection of TC-32 cells was performed 
with the Amaxa system (Amaxa, Cologne, 
Germany) according to the manufacturer's 
protocol, using 200 pmol of siRNA/106 cells. 
Effects of siRNA treatment were analyzed 48 h 
after transfection.  
    Immunofluorescence analysis and antibodies. 
TC-32 cells were seeded on collagen-coated glass 
coverslips (Fisher, Pittsburgh, PA) in complete 
growth medium. Fixation and staining were 
performed as previously described (10). Mouse 
FLAG (M2) antibody was from Sigma-Aldrich 
and Alexa Fluor 488 goat anti-mouse IgG was 
from Invitrogen. Fluorescent images were 
collected as described (43)  
    In vitro kinase assay and mass spectrometry 
analysis. Mouse Dvl2 cDNA was generated by 
PCR from pCS2+-Flag-mouse Dvl2 (a gift of S. B. 
Lee, National Institutes of Health, Bethesda, MD) 
and cloned into a pGEX-4T-2 vector (Amersham 
Biosciences, Piscataway, NJ).  Similarly, a SmaI-
NotI fragment of human CK1 was generated by 
PCR from pCS2+-Myc6-CK1 (a gift of D. 
Virshup, Duke-NUS Graduate Medical School, 
Singapore) and inserted into pGEX-4T-2.  GST-
Dvl2 and GST-CK1 were purified from E. coli 
BL21 (DE3) with glutathione (GSH)-agarose 
(Sigma). In vitro kinase reactions were carried out 
in 50 mM Tris-Cl (pH 7.5), 10 mM MgCl2, 5 mM 
dithiothreitol, 2 mM EGTA, 0.5 mM Na3VO4, and 
20 mM p-nitrophenyl phosphate in the presence of 
100 μM ATP at 30C for 30 min. Samples were 
separated by 10% SDS-PAGE. The GST-Dvl2 
band was excised and in-gel digested with trypsin 
(Promega). Tryptic peptides were separated using 
nanoflow reversed-phase liquid chromatography, 
coupled online to an LTQ linear ion trap or LTQ-
Orbitrap XL mass spectrometer (Thermo Electron, 
San Jose, CA) for MS/MS and MS/MS/MS 
analysis. The mass spectrometer was operated in a 
data-dependent mode to sequentially acquire MS, 
MS2 and neutral phosphate loss-dependent MS3 
spectra with dynamic exclusion. Normalized 
collision energy was 35% for both MS2 and MS3. 
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The raw MS2 and MS3 data were searched using 
SEQUEST (Thermo Electron) to identify 
phosphopeptides. These were subjected to 
validation of peptide sequence and 
phosphorylation sites by examining the 
corresponding MS2 and/or MS3 spectra.  
    Statistical analysis. The significance of 
differences in data was determined with Student’s 
t-test. Differences were considered significant 
when p value was less than 0.05. 
 
RESULTS 
    Mapping Wnt-induced phosphorylation sites in 
Dvl2 associated with mobility shift.  The 
phosphorylation of Dvl induced by Wnt signaling 
results in altered mobility of the protein with the 
phosphorylated-and-shifted form, psDvl, being 
noticeably retarded on polyacrylamide gels.  We 
have previously reported that the Dvl2 monoclonal 
antibody (mAb) 10B5 is selectively deficient in 
recognizing psDvl2, although it readily detects the 
unmodified, or faster migrating, band (12).  This 
phenomenon is illustrated in Figure 1A, both for 
endogenous Dvl2 in Rat2 cells and for exogenous 
Myc-tagged human Dvl2.  The inability of 10B5 
to detect psDvl2 suggests that the epitope is 
masked by Wnt-induced phosphorylation.  To 
identify the site of this phosphorylation, we 
mapped the 10B5 epitope.  As the antibody was 
raised against the C-terminal domain of Dvl2 (aa 
594-736), a series of C-terminal deletion mutants 
of Dvl2-Myc were generated and analyzed by 
Western blotting with both Myc antibody and 
mAb 10B5 (Figure 1B and 1C).  The shortest 
construct that still reacted with both antibodies 
was Dvl2127, containing amino acids 1-609.  
Thus, our results placed the epitope within a 16 
amino acid sequence from residues 594 to 609 
(Figure 1D).  This sequence contains two serine 
and two threonine residues as potential 
phosphorylation sites, three of which are clustered 
as STRS at position 594-597.  As all three Dvl 
proteins undergo Wnt-induced phosphorylation 
and mobility shift  (12,34), we examined the 
equivalent regions of Dvl1 and Dvl3. The STRS 
motif is perfectly conserved in Dvl1, while the 
equivalent sequence in Dvl3 is SNRS (Fig. 1D).   
    To investigate whether in vivo phosphorylation 
of specific amino acid residues within the 16 aa 
10B5 epitope is necessary for the Wnt-induced 
mobility shift of Dvl2, we individually mutated 
each of the four Ser and Thr residues to Ala in a 
Myc-tagged human Dvl2 cDNA and stably 
expressed the constructs in Rat2 cells by retroviral 
transduction.  Mobility of the mutant proteins was 
then examined on Western blots of cells treated 
with or without Wnt3a conditioned medium (CM).  
No individual Ser/Thr mutation prevented the 
phosphorylation-dependent mobility shift.  
However, for each of the mutants S594A and 
S597A only about 50% of the protein showed 
slower mobility in response to Wnt3a, indicating 
that the absence of either of these serines partially 
impairs formation of psDvl2 (Fig. 2).  In contrast, 
we observed little or no inhibition of psDvl2 
formation in T595A or T604A mutants.  Apart 
from the S and T residues, the only other amino 
acid within the epitope region that is conserved in 
all three Dvl proteins is R603.  When this residue 
was mutated, Wnt-induced formation of psDvl2 
was unaffected, as detected by Myc antibody.  
However, even in the absence of Wnt treatment, 
the mutant protein was undetectable by the 10B5 
antibody (Fig. 2, lanes 13 and 14).  This indicates 
that R603 is a critical residue in the 10B5 epitope 
but is unrelated to Wnt-induced phosphorylation.  
    We next tested combinations of S→A and 
T→A mutations, again using a retrovirus vector to 
express Myc-tagged human Dvl2 proteins.  
Remarkably, mutation of all four Ser/Thr residues 
(P4m) of the epitope produced a protein that 
showed no shift in mobility in response to either 
Wnt3a or Wnt5a signaling (Fig. 3A and 3B).  
Reagents based on this set of mutations were used 
in most of the subsequent experiments. For 
comparison, the Wnt-dependent mobility shift of 
endogenous Dvl3 was maintained in the cell lines 
expressing the Dvl2 P4m mutant (Fig. 3A and 3B).  
We subsequently determined that a mutant, Dvl2 
P3m, having alanine substitutions only at S594, 
T595 and S597, also failed to undergo a Wnt-
dependent mobility shift (Fig. 3C). As Dvl2 P3m 
and P4m are deficient in the Wnt-induced 
phosphorylation that results in a mobility shift, we 
refer to them as WIP mutants.   
    The amino acid sequence of the 10B5 epitope is 
perfectly conserved between human and mouse 
Dvl2.  To confirm the properties of the Dvl2 P4m 
WIP mutation in mouse Dvl2, we introduced the 
same four S→A and T→A changes into a FLAG-
tagged mDvl2 cDNA and expressed it in the 
human Ewing Sarcoma Family Tumor cell line 
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TC-32 by lentiviral transduction.  These cells 
display significant endogenous Wnt activity, 
which is associated with a basal level of neurite 
outgrowth (10).  Accordingly, exogenous mDvl2 
wild-type (WT) protein was spontaneously 
phosphorylated and shifted on Western blots (Fig. 
3D).  However, this shift was abolished by treating 
the cells for 3 h with the Wnt ligand antagonist 
sFRP1, consistent with the mobility shift being 
due to endogenous Wnt production (Fig 3D, lane 
3).  In contrast, mDvl2 P4m protein showed no 
phosphorylation-related mobility shift and was 
unaffected by sFRP1 (Fig. 3D, lanes 4-6).  This 
confirmed that the P4m mutations eliminate the 
phosphorylation-dependent mobility shift in Dvl2 
caused by Wnt signaling. 
    WIP mutant Dvl2 shows elevated activity in 
canonical Wnt signaling.   The WIP mutant is not 
only resistant to Wnt-induced phosphorylation at 
the 10B5 epitope, but it fails to undergo the 
conformational change that presumably underlies 
the altered electrophoretic mobility.  This mutant 
is therefore well suited for studying the functional 
impact of Dvl2 phosphorylation in Wnt signaling. 
    Although the ability of Wnts to induce Dvl 
phosphorylation is associated with non-canonical 
signaling, it also occurs in response to Wnts that 
concurrently activate the β-catenin pathway (12).  
To investigate the functional consequences of Dvl 
phosphorylation in Wnt signaling, we first tested 
the hypothesis that the Dvl2 WIP mutant might 
show altered activity in canonical signaling assays.  
As previously noted (25), transient overexpression 
of hDvl2 WT in 293T cells gives robust activation 
of the TCF/β-catenin-dependent luciferase reporter 
TOPflash in a dose-dependent manner (Fig. 4A).  
Parallel transfections with the WIP mutant Dvl2 
P4m also activated TOPflash.  However, at lower 
doses of input DNA, the signal from hDvl2 P4m 
was significantly stronger than from hDvl2 WT 
(Fig. 4A).  This suggested that the WIP mutant is 
moderately hyperactive in β-catenin signaling.  
We also analyzed cytosolic β-catenin by 
immunoblotting to compare the responsiveness of 
these cells to varying Wnt3a concentrations. While 
a 1:125 dilution of Wnt3a CM elicited only a 
small accumulation of β-catenin in cells 
expressing hDvl2 WT, we observed a larger 
increase in cells expressing hDvl2 P4m (Fig. 4B). 
Similarly, when mDvl2 WT and P4m constructs 
were transiently expressed in C57MG mouse 
mammary epithelial cells, the Wnt3a-dependent 
induction of β-catenin target genes Axin2 and 
RhoU (47) was stronger with Dvl2 P4m than Dvl2 
WT (Fig. 4C and 4D). Although the differential 
effects were not dramatic, these experiments 
suggested that expression of the Dvl2 WIP mutant 
enhanced the sensitivity of cells to Wnt3a.  This 
implies that Wnt-induced Dvl2 phosphorylation at 
the identified sites has a modest negative effect on 
canonical signaling. 
    WIP mutant Dvl2 preferentially accumulates in 
puncta.    Both endogenous and overexpressed Dvl 
proteins are known to form cytoplasmic puncta 
(48,49).  These puncta are thought to result from 
dynamic polymerization of Dvl proteins, and to 
some extent correlate with activation of Wnt/β-
catenin signaling (24-26). When we examined the 
intracellular distribution of FLAG-tagged mDvl2 
WT and mDvl2 P4m stably expressed in TC-32 
cells, we observed three different FLAG staining 
patterns: (1) diffuse cytoplasmic; (2) combination 
of cytoplasmic and puncta; (3) puncta dominant 
(Fig. 5A). Quantitative analysis revealed that 64% 
of cells expressing mDvl2 WT had a diffuse 
cytoplasmic pattern, 32% had a mixed pattern and 
3% were puncta dominant. In contrast, only 15% 
of cells expressing mDvl2 P4m exhibited a diffuse 
cytoplasmic distribution, while 78% had a mixed 
pattern and 6% were puncta dominant (Fig. 5B).  
Similar profiles were seen in the presence and 
absence of Wnt3a treatment with or without 
siRNA knockdown of endogenous Dvl2/3 
expression (data not shown). The enhanced 
accumulation of P4m in puncta is consistent with 
its stimulation of -catenin signaling.  
    WIP mutant Dvl2 does not mediate Wnt3a-
dependent neurite outgrowth in TC-32 cells.  
Wnt3a induces neurite outgrowth in TC-32 cells 
via non-canonical Wnt signaling, and Dvl proteins 
are required for this process (10). Moreover, a 
Wnt3a-dependent Dvl mobility shift correlates 
with neurite outgrowth in these cells (43). Using 
this experimental model as a readout for non-
canonical Wnt signaling, we compared the ability 
of siRNA-resistant mDvl2 WT vs. P4m proteins to 
rescue Wnt-induced neurite outgrowth after 
knockdown of endogenous Dvl2/3. Dvl2/3 siRNA 
markedly blocked Wnt-3a-dependent neurite 
outgrowth in parental TC-32 cells (Fig. 6A).  
However, neurite extension was not inhibited in 
cells expressing mDvl2 WT. In contrast, mDvl2 
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P4m failed to rescue neurite outgrowth. Moreover, 
expression of P4m also blocked Wnt3a-induced 
neurite outgrowth in the presence of endogenous 
Dvl2/3 (Fig. 6A). mDvl2 WT and P4m proteins 
were expressed at similar levels and knockdown of 
endogenous Dvl2/3 proteins was comparable in 
the various cell lines, indicating that differences in 
expression did not account for their distinct effects 
(Fig. 6B). Interestingly, levels of both FLAG-
tagged Dvl2 WT and P4m were significantly 
increased, and to a similar extent, after siRNA 
knockdown of endogenous Dvl2/3 (Fig. 6B).  
Nonetheless, the results from these experiments 
clearly demonstrate that the Dvl2 WIP mutant was 
unable to support neurite outgrowth, implying that 
it was defective in mediating the requisite non-
canonical Wnt signaling. 
    CK1δ phosphorylates CTD residues responsible 
for the WIP-dependent mobility shift.  Previous 
studies have demonstrated that knockdown of 
endogenous CK1δ and CK1ε with small 
interfering RNA blocks the Wnt-dependent psDvl 
mobility shift  (39,43).  We therefore performed an 
in vitro kinase assay with purified CK1δ and 
hDvl2, followed by tryptic digestion and mass 
spectrometry analysis, to determine whether the 
residues implicated in the mobility shift were 
targets of CK1 phosphorylation.  While several 
phosphorylation sites were detected elsewhere in 
the hDvl2 sequence (unpublished observations, 
KHL), we recovered multiple phosphopeptides 
with phosphorylation at residues S594, T596, and 
S597, but not T604 (Table 1).  In addition, S591 
and S592 were phosphorylated.  Thus, each of the 
amino acid residues S594, T595 and S597 
conforms to the consensus CK1 phosphorylation 
site pS/pT–X1-3–S/T, where underlined residues 
are the target sites. As previously noted, a Dvl2 
triple mutant with alanine substitutions at these 
residues (P3m) did not undergo a mobility shift 
following Wnt3a treatment (Fig. 3C).  Taken 
together, our data indicate that the Wnt-dependent 
psDvl2 mobility shift is due to CK1δ/ε 
phosphorylation of these three residues. 
 
DISCUSSION 
    In this study we have identified Wnt-induced 
phosphorylation (WIP) sites at Ser594, Thr595, 
and Ser597 in Dvl2 that have functional 
consequences for both canonical and non-
canonical signaling.  These sites have particular 
significance among other phosphorylation sites 
that have been mapped on Dvl proteins in the past.  
First, phosphorylation of the WIP sites is induced 
by Wnt ligand signaling rather than by 
overexpression of individual kinases.  Second, the 
phosphorylation of these sites is required for the 
Wnt-mediated Dvl2 electrophoretic mobility shift 
that is routinely used as an assay for Dvl 
phosphorylation, and also serves as an assay for 
non-canonical Wnt signal transduction events  
(12,20).  Although two amino acids in the DIX 
domain of Dvl2, K68 and E69, were previously 
shown to be required for formation of psDvl2, 
these residues are not phosphorylated but instead 
affect subcellular Dvl2 distribution (50). 
    Several previous studies have implied that 
CK1δ and CK1ε are primarily responsible for the 
Wnt-dependent mobility shift of Dvl2/3(30,39,43).  
Consistent with this notion, we found that the WIP 
sites identified here were phosphorylated by CK1 
in an in vitro kinase assay. Others have 
documented CK1 phosphorylation sites elsewhere 
in Dvl protein (36) and we also detected 
phosphorylation of other residues in our in vitro 
kinase assay (data not shown).  In view of the 
abundance of potential phosphorylation targets 
throughout the Dvl2 amino acid sequence, 
therefore, the abolition of mobility shifting by 
mutation of these three residues alone is perhaps 
unexpected.  However, we suggest that 
phosphorylation of the WIP sites may be a 
necessary priming event that allows further 
phosphorylation at other sites, and/or that WIP site 
phosphorylation in conjunction with other 
phosphorylated sites creates a critical mass of 
charged residues sufficient to bring about the 
presumed conformational change in Dvl protein 
that causes its electrophoretic retardation.  In this 
regard it is notable that, in overexpression 
experiments, CK1 and CK1ε can induce 
phosphorylation at sites in Dvl2 other than the 
WIP sites and that this in turn can cause mobility 
shifting (data not shown).  A similar finding was 
recently reported for a Dvl3 CTD deletion mutant 
(39).  Nevertheless, our results demonstrate that 
when Dvl phosphorylation is triggered by Wnt 
ligands, mutation of the WIP sites prevents 
mobility shifting in cells expressing endogenous 
levels of CK1δ/ε.  Thus, these sites are likely to 
have physiologic relevance. 
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    Mutation of the WIP sites of Dvl2 provided a 
unique opportunity to investigate the functional 
consequences of preventing Wnt-induced 
phosphorylation of mammalian Dvl without 
alterations in the activity of kinases that might 
have pleiotropic effects.  To some extent our 
conclusions differ from an extensive analysis of 
Dishevelled (Dsh) phosphorylation in Drosophila, 
which concluded that Ser/Thr phosphorylation did 
not have functional significance in -catenin or 
PCP signaling (35).  However, the authors of that 
study acknowledged the possibility that 
phosphorylation of mammalian Dvls at residues 
not conserved in Drosophila might be functionally 
relevant, especially in pathways that were not 
operative in their assays.  These caveats apply to 
the S594T595R596S597 sequence we identified in 
Dvl2, as it is located in a region poorly conserved 
in Drosophila but well conserved in mammals and 
other vertebrates (51).   
    Our functional testing of Dvl2 WIP mutants 
suggests that phosphorylation of these three 
Ser/Thr residues has a mild inhibitory effect on 
canonical Wnt/-catenin signaling, as the alanine 
substitution mutant Dvl2 P4m appeared more 
active than Dvl2 WT in assays of β-catenin-
mediated transcription.  More strikingly, and in 
contrast, Dvl2 P4m was unable to rescue Wnt3a-
induced neurite outgrowth in TC-32 cells.  We 
have previously reported that Wnt-mediated 
neurite extension in these cells does not require the 
canonical Wnt/β-catenin pathway receptor LRP5/6 
and instead is mediated by non-canonical Wnt 
pathways that rely on JNK and atypical PKC iota 
(PKC) (10)(Greer et al., submitted). In the 
accompanying manuscript we further show that 
Dvl2 P4m, in contrast to Dvl2 WT, fails to co-
immunoprecipitate with PKC and this may 
account for its inability to mediate neurite 
outgrowth (Greer et al., submitted).  The inactivity 
of Dvl2 P4m in the neurite assay indicates that it 
cannot transduce an essential non-canonical signal 
and hence that phosphorylation of the Dvl2 WIP 
sites normally promotes this function. 
    In apparent contrast to our results concerning 
the impact of Wnt-induced, CK1δ/ε-dependent 
Dvl2 phosphorylation on -catenin signaling, a 
number of previous studies have implicated 
CK1δ/ε as a positive mediator of the canonical 
pathway (52,53). One explanation of this may 
stem from the ability of overexpressed CK1δ/ε to 
phosphorylate several other Wnt signaling 
components besides Dvl and thus to exert a 
combination of positive and negative effects on 
the pathway as a whole (40).  In addition, there 
appear to be differential effects of CK1-mediated 
phosphorylation at different sites within Dvl 
proteins.  For example, a recent report indicated 
that CK1ε phosphorylation of Dvl3 at upstream 
sites correlated with stimulation of canonical 
signaling, while phosphorylation in the CTD was 
associated with attenuation of the signal (39).  The 
consequences we describe here for 
phosphorylation of the WIP sites in the CTD of 
Dvl2 are consistent with that report. 
    We also examined the effect of WIP site 
mutation on subcellular distribution of Dvl2 
protein, especially with regard to formation of the 
cytoplasmic puncta that are associated with 
Wnt/-catenin signaling (24,25,27,50).  Our 
observation that Dvl2 P4m preferentially localized 
to puncta relative to Dvl2 WT (Fig. 5) is consistent 
with this view, as the mutant was more potent in 
assays of canonical Wnt/β-catenin signaling.  Our 
findings are also in agreement with those of 
Bernatik et al. (39) who noted increased 
localization in puncta of a ps-deficient Dvl3 
deletion derivative that showed enhanced activity 
in the -catenin pathway.  The results from these 
studies together reinforce the idea that 
phosphorylation in the CTD is associated with 
diminished -catenin signaling.  Others have not 
specifically addressed the possibility that 
phosphorylation of the CTD would have a positive 
effect on other Dvl activities, and this is an 
important additional conclusion from our study.  
Phosphorylation at the CTD WIP sites might 
therefore serve as a switch to redirect Dvl function 
towards non-canonical signaling.  This may have 
particular relevance for Wnt ligands that can 
stimulate both canonical and non-canonical 
pathways (12).  In view of the 20-30 minute time 
lag before induction of psDvl2, there may be 
attenuation of canonical signaling over time via 
this mechanism.   
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FIGURE LEGENDS 
Fig. 1. Deletion mapping of Wnt-induced phosphorylation sites in Dvl2 associated with 
mobility shift and mAb 10B5 epitope recognition.  (A) Immunoblots showing Wnt-induced 
mobility shift of endogenous (left panels) and exogenous (right panels) Dvl2 proteins, and the 
inability of mAb 10B5 to detect the mobility shifted forms.  Rat2 fibroblasts transduced with 
control retroviral vector (left panels), or vector expressing Myc-tagged hDvl2 (right panels), 
were treated with Wnt3a conditioned medium (CM) for 2 h and lysates were processed for 
western analysis with the indicated antibodies.  Bands corresponding to hypophosphorylated 
(Dvl2) or phosphorylated and shifted Dvl2 (psDvl2) are indicated. The expected locations of 
psDvl and ps-hDvl2-Myc are indicated in the lower panels but the bands are undetectable with 
mAb 10B5.  (B) Schematic diagram of Dvl2 C-terminal deletion mutants. Sequences of full-
length hDvl2 (1-736 residues) and truncated derivatives are represented, along with positions of 
the modular domains, DIX, b (basic region), PDZ, and DEP.  Sequences present in the 
immunogen for MAb 10B5 (594-736) are indicated in grey.  (C) Immunoblots of Myc-tagged 
hDvl2 full-length and deletion constructs transiently transfected in HEK293T cells.  Proteins 
were detected with mAb 10B5 or anti-Myc. Molecular mass markers are indicated. (D) Sequence 
comparison of human Dvl isoforms in region corresponding to deduced 10B5 epitope.  Extent of 
epitope is demarcated by the box. Potential Ser/Thr phosphorylation sites within epitope are 
highlighted in black.  Epitope residues conserved in all 3 Dvl proteins are designated with *. 
 
Fig. 2. Site-directed mutagenesis identified individual residues that contribute to Dvl2 
mobility shift. Each of the S/T residues and conserved R603 in the putative epitope of the Dvl2 
mAb 10B5 were mutated as indicated and Myc-tagged hDvl2 derivatives were stably expressed 
in Rat2 cells by retroviral transduction.  After incubation for 2 h with Wnt3a CM or control CM, 
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cell lysates were analyzed by immunoblotting with anti-Myc and Dvl2 10B5 antibodies.  Bands 
corresponding to endogenous and exogenous Dvl2 and psDvl2 are indicated. 
 
Fig. 3. Wnt-dependent mobility shift of Dvl2 WT vs. P4m and P3m mutants. Western blot 
analysis of Rat2 cells stably transduced with Myc-tagged hDvl2 WT, hDvl2 P4m or empty 
retroviral vector and incubated overnight with Wnt3a CM (A) or Wnt5a CM (B).  Exogenous 
Myc-tagged Dvl2 was detected with anti-Myc (upper panels). Dvl3 was probed for comparison 
(lower panels), providing a positive control for Wnt-induced phosphorylation of endogenous 
Dvl, and GSK3 served as a loading control. (C) A similar analysis was performed with Rat2 
cells stably expressing Myc-tagged hDvl2 WT, P4m or P3m and treated with Wnt3a CM. (D)  
Immunoblot of FLAG-tagged mDvl2 WT and 4Pm in TC-32 cells with or without sFRP1 
treatment.  HSP70 served as a loaded control.   
 
Fig. 4. WIP mutant exhibits greater activity than hDvl2 WT in the -catenin pathway. (A) 
Topflash reporter assay in 293T cells. Cells were transiently transfected with Topflash reporter 
and empty vector (negative control), -catenin cDNA (positive control), or varying amounts of 
hDvl2 WT or hDvl2 P4m expression constructs. Results were normalized to activity obtained 
with empty vector (50 ng/well). (B) -catenin stabilization in Rat2 cells stably transduced with 
hDvl2 WT or P4m vectors.  Cells were treated with the indicated dilutions of Wnt3a CM and 
lysates were blotted for -catenin and GSK-3; the latter was a loading control.  At low doses of 
Wnt3a, cells expressing P4m were more sensitive to -catenin stablization than those expressing 
hDvl2 WT. The experiment was performed twice with similar results. (C and D) C57MG cells 
were transiently transfected with empty vector, FLAG-tagged mDvl2 WT or P4m constructs and 
subsequently incubated with or without Wnt3a (50 ng/ml) for 6 h. Quantitative RT-PCR analysis 
of Axin2 (C) and RhoU transcripts (D) was normalized to -actin transcript and expressed in 
arbitrary units with 1 unit = expression in cells transfected with empty vector and incubated in 
the absence of Wnt3a.  Results are the mean of triplicate measurements + S.D. from one of two 
experiments that yielded similar data. 
 
Fig. 5. Intracellular distribution of FLAG-tagged mDvl2 WT and mDvl2 P4m in TC-32 
cells. (A) Representative micrographs of FLAG-mDvl2 distribution illustrating three patterns:  
cytoplasmic; cytoplasmic and puncta; puncta predominant. (B) Cumulative quantitative analysis 
of distribution patterns for mDvl2 WT and P4m.  N indicates the number of cells examined for 
each construct.  
 
Fig. 6. Contrasting activity of FLAG-tagged mDvl2 WT vs. mDvl2 P4m in neurite 
outgrowth assay. (A) Parental TC-32 cells and cells stably expressing FLAG-tagged mDvl2 WT 
or mDvl2 P4m were treated with siRNA reagents targeting luciferase (negative control) or Dvl2 
and Dvl3, and 48 h later incubated with medium +/- Wnt3a (100 ng/ml) for 3 h.  Following 
fixation, neurite outgrowth was assessed in dozens of cells from each treatment group.  The 
results from three separate experiments are indicated, mean and S.D.  Statistical significance of 
selected pairwise comparisons is indicated. (B) Western blot analysis of Dvl2/3 expression in 
cells treated as described in (A).  Efficacy of Dvl2/3 siRNA is evident.  HSP70 was a loading 
control.  Position of molecular mass markers is indicated. 
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In vitro kinase 
reaction Peptides identified Phosphosites  Region 
CK1 + Dvl2 
R.SSGSTRSDGGAGR.T  S591, S594
590 - 604 R.SSGSTRSDGGAGR.T S591, T595
R.SSGSTRSDGGAGR.T S592, S594, S597
R.SSGSTRSDGGAGR.T S591, T595, S597  
 
Table 1. Phosphopeptides derived from region 590-604 of hDvl2 after in vitro phosphorylation 
with CK1, detected by mass spectrometry.  Dots indicate sites of tryptic cleavage.  Underlines 
indicate phosphorylated residues. Boldface indicates phosphorylated residues implicated in 
psDvl2 mobility shift and 10B5 epitope.  
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